1) soluble endothelial cell protein C receptor
可溶性血管内皮细胞蛋白C受体
2) soluble endothelial protein C receptor
可溶性内皮细胞蛋白 C 受体
3) EPCR
血管内皮细胞蛋白C受体
1.
Objective To investigate dynamic plasma levels of plasma thrombomodulin(PTM) and the endothelial cell protein C receptor(EPCR) in patients with hepatic disease,and discuss the expression change during the process of hepatic disease and its clinical meanings.
目的探讨血浆凝血酶调节蛋白(PTM)和血管内皮细胞蛋白C受体(EPCR)在肝脏疾病患者病变过程中的表达变化及其临床意义。
4) Soluble VEGF receptor
可溶性血管内皮细胞生长因子受体
5) Endothelial protein C receptor
内皮细胞蛋白C受体
1.
Endothelial protein C receptor(EPCR)is a main component of protein C anticoagulant system.
内皮细胞蛋白C受体(EPCR)是蛋白C抗凝系统的主要组成部分。
2.
Objective To ascertain the frequency of endothelial protein C receptor (EPCR) gene A6936G variant and study the association between this mutation and deep venous thrombosis (DVT) in Chinese Han population of Hubei district.
目的了解湖北地区汉族人群内皮细胞蛋白C受体(EPCR)A6936G变异的分布频率,探讨其与深静脉血栓形成的关系。
3.
In order to explore the distribution frequency of endothelial protein C receptor(EPCR) gene A6936G variant and to study the correlation between this mutation and cerebral infarction in Chinese Han population of Hubei province district.
本研究旨在了解湖北省地区汉族人群内皮细胞蛋白C受体(EPCR)A6936G变异的分布频率,探讨其与脑梗塞的关系。
6) Endothelial cell protein C receptor
内皮细胞蛋白C受体
1.
Changes of plasma soluble endothelial cell protein C receptor and thrombomodulin levels in patients with type 2 diabetes mellitus;
2型糖尿病患者血浆可溶性内皮细胞蛋白C受体和血栓调节蛋白的变化
2.
Recent studies have suggested that acute lung injury is associated with increased procoagulant activity in the alveolar compartment and the protein C pathway is significantly altered in ALL Thrombomodulin (TM) and endothelial cell protein C receptor (EPCR) are major receptors for protein C activation.
本课题旨在研究人肺泡上皮细胞能否表达和释放活化蛋白C所需的两个受体一凝血酶调节素(TM)和内皮细胞蛋白C受体(EPCR)。
3.
Objective:To investigate the effects of the serum in hemorrhagic shock rats and Shenfu injection on endothelial cell\'s thrombomodul and endothelial cell protein C receptor.
目的:探讨失血性休克大鼠血清对人脐静脉内皮细胞内皮细胞蛋白C受体(EPCR)表达的影响。
补充资料：肝婴儿血管内皮细胞瘤
肝婴儿血管内皮细胞瘤
hepatic infantile hemangioendothelioma
类似毛细血管瘤的肝血管畸形疾病。有一定时期的自限病程，分增生、成熟、退化等几个阶段，如无危及生命的并发症，病变则最终消失。本病多在6个月内的婴儿得以确诊，女性多于男性；偶有成年病例的报道。常以肝大和/或腹部包块为主要临床表现，多同时伴有皮肤毛细血管瘤；部分患者因有动静脉瘘而出现充血性心力衰竭。有症状者约2/3会死于该病，死因有充血性心力衰竭、肝功能衰竭或肿瘤破裂出血。单发性者有手术切除机会；多发性则常不能手术切除，可选择肝动脉结扎或栓塞、放疗和皮质激素治疗等。个别可伴发血管肉瘤。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条